Immco Diagnostics develops and distributes autoimmune disease diagnostics and reagents to labs worldwide. Immco offers laboratory testing of autoimmune diseases for the US healthcare market. Its contract research organization supports clinical research trials for pharmaceutical and biotech clients.
Immco assay development led to the first immunofluorescence assay for diagnosing celiac disease and the first Western blot assay for autoimmune hearing loss. The new line of Immco enhanced ELISA assays provides standardized calibration systems, an industry first. Immco is continually expanding its product offering.
Immco’s principal mission is to provide the total solution in autoimmunity™.
Website: www.immcodiagnostics.com